Arcus Biosciences, Inc. (NYSE:RCUS) Given Average Rating of “Moderate Buy” by Analysts
Shares of Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) have received an average rating of “Moderate Buy” from the eight research firms that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12-month […]
More Stories
Head to Head Analysis: U Power (NASDAQ:UCAR) & Dorman Products (NASDAQ:DORM)
U Power (NASDAQ:UCAR – Get Free Report) and Dorman Products (NASDAQ:DORM – Get Free Report) are both auto/tires/trucks companies, but...
Village Farms International, Inc. (TSE:VFF) Director Buys C$12,552.30 in Stock
Village Farms International, Inc. (TSE:VFF – Get Free Report) Director Stephen Ruffini bought 10,000 shares of the firm’s stock in...
Jaguar Mining Inc. (TSE:JAG) Senior Officer Sells C$11,280.00 in Stock
Jaguar Mining Inc. (TSE:JAG – Get Free Report) Senior Officer Jonathan Victor Hill sold 2,000 shares of the firm’s stock...
Able View Global Inc. (NASDAQ:ABLV) Sees Significant Decline in Short Interest
Able View Global Inc. (NASDAQ:ABLV – Get Free Report) saw a significant decline in short interest in the month of...
Analysts Set enGene Holdings Inc. (NASDAQ:ENGN) Target Price at $33.67
enGene Holdings Inc. (NASDAQ:ENGN – Get Free Report) has been assigned an average recommendation of “Buy” from the seven analysts...
Brokerages Set Rubrik, Inc. (NYSE:RBRK) PT at $44.69
Rubrik, Inc. (NYSE:RBRK – Get Free Report) has earned a consensus recommendation of “Buy” from the seventeen brokerages that are...